Effect of beta-adrenoceptor blockade on the cardiovascular and hyperglycaemic actions of diazoxide.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D003981:Diazoxide / Q000494:pharmacology*; D004347:Drug Interactions; D006439:Hemodynamics / Q000187:drug effects*; D006470:Hemorrhage / Q000503:physiopathology; D008297:Male; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D000804:Angiotensin II; D011433:Propranolol; D003981:Diazoxide